Autoinflammatory Disease Clinical Trials
2 recruiting trials for Autoinflammatory Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Autoinflammatory Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Assistance Publique - Hôpitaux de Paris (1), University of Bonn (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Blood collection (other, 1 trial), followed by Ex Vivo Assay.
Track Autoinflammatory Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
The objective of this work is to identify, in patients with autoimmune diseases, systemic vasculitis and autoinflammatory disease, cytokine and lymphocyte biomarkers of activity...
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
The CARe RAiSE project represents a pioneering translational initiative aimed at advancing precision medicine in the treatment of autoimmune rheumatic diseases. The primary...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Autoinflammatory Disease, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Autoinflammatory Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Autoinflammatory Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.